HEADER HYDROLASE/HYDROLASE INHIBITOR 12-FEB-92 1HIV
TITLE CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A
TITLE 2 DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR
TITLE 3 MODELING
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIV-1 PROTEASE;
COMPND 3 CHAIN: A, B;
COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR N.THANKI,A.WLODAWER
REVDAT 5 23-OCT-24 1HIV 1 COMPND REMARK HETNAM LINK
REVDAT 4 29-NOV-17 1HIV 1 HELIX
REVDAT 3 13-JUL-11 1HIV 1 VERSN
REVDAT 2 24-FEB-09 1HIV 1 VERSN
REVDAT 1 31-OCT-93 1HIV 0
JRNL AUTH N.THANKI,J.K.RAO,S.I.FOUNDLING,W.J.HOWE,J.B.MOON,J.O.HUI,
JRNL AUTH 2 A.G.TOMASSELLI,R.L.HEINRIKSON,S.THAISRIVONGS,A.WLODAWER
JRNL TITL CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A
JRNL TITL 2 DIHYDROXYETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH
JRNL TITL 3 MOLECULAR MODELING.
JRNL REF PROTEIN SCI. V. 1 1061 1992
JRNL REFN ISSN 0961-8368
JRNL PMID 1304383
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PROLSQ
REMARK 3 AUTHORS : KONNERT,HENDRICKSON
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : NULL
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING + TEST SET) : 0.169
REMARK 3 R VALUE (WORKING SET) : NULL
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1516
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 59
REMARK 3 SOLVENT ATOMS : 90
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : 0.020 ; 0.020
REMARK 3 ANGLE DISTANCE (A) : 0.049 ; 0.035
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.056 ; 0.050
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : 0.017 ; 0.020
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.201 ; 0.150
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : 0.191 ; 0.300
REMARK 3 MULTIPLE TORSION (A) : 0.201 ; 0.300
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : 0.185 ; 0.300
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : 2.800 ; 3.000
REMARK 3 STAGGERED (DEGREES) : 17.600; 10.000
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.475 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.210 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 4.215 ; 3.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.934 ; 4.000
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1HIV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000173877.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : NULL
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : NULL
REMARK 200 RADIATION SOURCE : NULL
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL
REMARK 200 WAVELENGTH OR RANGE (A) : NULL
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL
REMARK 200 RESOLUTION RANGE HIGH (A) : NULL
REMARK 200 RESOLUTION RANGE LOW (A) : NULL
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : NULL
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 41.56
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.95000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.30000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.95000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.30000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 316 O HOH A 386 2455 2.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 8 NE - CZ - NH2 ANGL. DEV. = 4.6 DEGREES
REMARK 500 VAL A 11 O - C - N ANGL. DEV. = 9.7 DEGREES
REMARK 500 ASP A 25 N - CA - CB ANGL. DEV. = -16.9 DEGREES
REMARK 500 ASP A 25 CB - CG - OD1 ANGL. DEV. = 8.8 DEGREES
REMARK 500 ASP A 29 CB - CG - OD1 ANGL. DEV. = 11.6 DEGREES
REMARK 500 ASP A 29 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES
REMARK 500 ASP A 30 CB - CG - OD2 ANGL. DEV. = -8.2 DEGREES
REMARK 500 ASP A 30 O - C - N ANGL. DEV. = 9.6 DEGREES
REMARK 500 GLU A 35 OE1 - CD - OE2 ANGL. DEV. = 9.8 DEGREES
REMARK 500 GLU A 35 CG - CD - OE2 ANGL. DEV. = -13.8 DEGREES
REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES
REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = 4.0 DEGREES
REMARK 500 ILE A 50 CA - CB - CG2 ANGL. DEV. = 15.1 DEGREES
REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 12.8 DEGREES
REMARK 500 LEU B 5 CB - CG - CD1 ANGL. DEV. = -10.5 DEGREES
REMARK 500 ASP B 25 CB - CG - OD1 ANGL. DEV. = 7.2 DEGREES
REMARK 500 ASP B 29 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES
REMARK 500 ASP B 29 CB - CG - OD2 ANGL. DEV. = -7.0 DEGREES
REMARK 500 LEU B 33 O - C - N ANGL. DEV. = 10.2 DEGREES
REMARK 500 GLU B 35 CG - CD - OE2 ANGL. DEV. = -13.3 DEGREES
REMARK 500 MET B 36 CA - CB - CG ANGL. DEV. = 15.8 DEGREES
REMARK 500 MET B 46 CA - CB - CG ANGL. DEV. = -12.2 DEGREES
REMARK 500 PHE B 53 CB - CG - CD2 ANGL. DEV. = -4.4 DEGREES
REMARK 500 GLU B 65 OE1 - CD - OE2 ANGL. DEV. = 8.9 DEGREES
REMARK 500 VAL B 75 CA - CB - CG1 ANGL. DEV. = 9.7 DEGREES
REMARK 500 ILE B 84 O - C - N ANGL. DEV. = 11.3 DEGREES
REMARK 500 ARG B 87 NH1 - CZ - NH2 ANGL. DEV. = -7.6 DEGREES
REMARK 500 ARG B 87 NE - CZ - NH2 ANGL. DEV. = 5.2 DEGREES
REMARK 500 CYS B 95 CB - CA - C ANGL. DEV. = 7.3 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO B 79 42.65 -77.93
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE SUBCOMPONENT CAV IN INHIBITOR 1ZK IS THE DIPEPTIDE
REMARK 600 ISOSTERE CYCLOHEXYL ALANINE PSI(CHOH-CHOH)VALINE. THE
REMARK 600 VALINE HAS A C-OH GROUP IN PLACE OF THE USUAL MAIN CHAIN
REMARK 600 N ATOM.
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(CYCLOHEXYLMETHYL)-2,3-
REMARK 630 DIHYDROXY-5-METHYL-4-({(1S,2R)-2-METHYL-1-[(PYRIDIN-2-YLMETHYL)
REMARK 630 CARBA MOYL]BUTYL}CARBAMOYL)HEXYL]AMINO}-2-{[(NAPHTHALEN-1-YLOXY)
REMARK 630 ACETYL]AMINO}-3-OXOPROPYL]-1H-IMIDAZOL-3-IUM
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 1ZK A 100
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: NOA HIS CAV ILE APY
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1ZK A 100
DBREF 1HIV A 1 99 UNP P04585 POL_HV1H2 57 155
DBREF 1HIV B 1 99 UNP P04585 POL_HV1H2 57 155
SEQRES 1 A 99 PRO GLN VAL THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU
SEQRES 6 A 99 ILE CSO GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN VAL THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE LEU ILE GLU
SEQRES 6 B 99 ILE CSO GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE
MODRES 1HIV CSO A 67 CYS S-HYDROXYCYSTEINE
MODRES 1HIV CSO B 67 CYS S-HYDROXYCYSTEINE
HET CSO A 67 7
HET CSO B 67 7
HET 1ZK A 100 59
HETNAM CSO S-HYDROXYCYSTEINE
HETNAM 1ZK 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(CYCLOHEXYLMETHYL)-2,3-
HETNAM 2 1ZK DIHYDROXY-5-METHYL-4-({(1S,2R)-2-METHYL-1-[(PYRIDIN-2-
HETNAM 3 1ZK YLMETHYL)CARBA MOYL]BUTYL}CARBAMOYL)HEXYL]AMINO}-2-
HETNAM 4 1ZK {[(NAPHTHALEN-1-YLOXY)ACETYL]AMINO}-3-OXOPROPYL]-1H-
HETNAM 5 1ZK IMIDAZOL-3-IUM
HETSYN 1ZK U75875
FORMUL 1 CSO 2(C3 H7 N O3 S)
FORMUL 3 1ZK C45 H62 N7 O7 1+
FORMUL 4 HOH *90(H2 O)
HELIX 1 HA GLY A 86 GLY A 94 1 9
HELIX 2 HB GLY B 86 GLY B 94 1 9
SHEET 1 COA 8 LYS A 43 GLY A 49 0
SHEET 2 COA 8 GLY A 52 ILE A 66 -1
SHEET 3 COA 8 HIS A 69 GLY A 78 -1
SHEET 4 COA 8 THR A 31 GLU A 34 1
SHEET 5 COA 8 ASN A 83 ILE A 85 -1
SHEET 6 COA 8 GLN A 18 ASP A 25 1
SHEET 7 COA 8 PRO A 9 ILE A 15 -1
SHEET 8 COA 8 GLU A 65 ILE A 66 -1
SHEET 1 COB 8 LYS B 43 GLY B 49 0
SHEET 2 COB 8 GLY B 52 ILE B 66 -1
SHEET 3 COB 8 HIS B 69 GLY B 78 -1
SHEET 4 COB 8 THR B 31 GLU B 34 1
SHEET 5 COB 8 ASN B 83 ILE B 85 -1
SHEET 6 COB 8 GLN B 18 ASP B 25 1
SHEET 7 COB 8 PRO B 9 ILE B 15 -1
SHEET 8 COB 8 GLU B 65 ILE B 66 -1
SHEET 1 INT 4 PRO A 1 THR A 4 0
SHEET 2 INT 4 THR B 96 PHE B 99 -1
SHEET 3 INT 4 THR A 96 PHE A 99 -1
SHEET 4 INT 4 PRO B 1 THR B 4 -1
LINK C ILE A 66 N CSO A 67 1555 1555 1.33
LINK C CSO A 67 N GLY A 68 1555 1555 1.30
LINK C ILE B 66 N CSO B 67 1555 1555 1.33
LINK C CSO B 67 N GLY B 68 1555 1555 1.29
SITE 1 AC1 18 ARG A 8 ASP A 25 GLY A 27 ALA A 28
SITE 2 AC1 18 ASP A 29 GLY A 48 GLY A 49 ILE A 50
SITE 3 AC1 18 PRO A 81 HOH A 301 HOH A 339 ASP B 25
SITE 4 AC1 18 GLY B 27 ALA B 28 ASP B 29 GLY B 48
SITE 5 AC1 18 GLY B 49 VAL B 82
CRYST1 52.000 58.600 61.900 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019231 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017065 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016155 0.00000